Weissman Explains “Turning Genes On and Off with CRISPRa and CRISPRi”

IGI Co-Director Jonathan Weissman describes exciting work from his lab and others that may one day enable effective therapies for flu, cancer, and more. He explains how CRISPR has been repurposed to “adjust the volume” of genes, turning them up or down, providing scientists with an unprecedented ability to figure out how genes contribute to disease.

Turning Genes On and Off with CRISPRa and CRISPRi
William Morris Endeavor 2016 Retreat | Carlsbad, CA | January 7, 2016